Shares of Johnson & Johnson (JNJ) are lower in morning trading on Wednesday following a NY Times article detailing a lawsuit in which it is alleged that major pharmaceutical companies JNJ and Bayer (BAYRY) deceived The New England Journal of Medicine by leaving out critical laboratory data over their Xarelto drug. — BMO Capital initiated […]
View the full post at: Morning Buzz: Johnson & Johnson (JNJ), Amazon.com (AMZN), Facebook (FB), Chesapeake Energy (CHK)